TLX Telix Pharmaceuticals Ltd
- 19.515
- +0.325+1.69%
Telix Pharmaceuticals Ltd News
Cochlear Limited (CHEOF) Gets a Hold From Jarden
Analysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals Ltd. (OtherTLPPF), CSL (OtherCMXHF) and Neuren Pharmaceuticals Limited (OtherNURPF)
Telix Pharmaceuticals Target Price Cut 5.8% to A$21.30/Share by Bell Potter>TLX.AU
Analysts Offer Insights on Healthcare Companies: Telix Pharmaceuticals Ltd. (OtherTLPPF) and American Well (AMWL)
Analysts Are Bullish on These Healthcare Stocks: Telix Pharmaceuticals Ltd. (TLPPF), Warby Parker (WRBY)
Jefferies Remains a Buy on Telix Pharmaceuticals Ltd. (TLPPF)
Telix Pharmaceuticals Price Target Cut 3.6% to A$31.90/Share by Jefferies
Up 86% in 2024, Why Is the Telix Pharmaceuticals Share Price Tumbling Today?
FDA Denies Telix Pharmaceuticals' License Application; Shares Fall 4.3%
Why Brainchip, Gold Road, Mesoblast, and Telix Shares Are Tumbling Today
Telix Pharmaceuticals Completes AU$650 Million Convertible Bond Issue
Telix Pharmaceuticals Target Price Raised 0.3% to A$22.55/Share by Jarden>TLX.AU
Why Argosy Minerals, Flight Centre, Mesoblast, and Telix Shares Are Sinking Today
Telix Pharmaceuticals Share Price Sinks 5% on Giant Debt Deal
Telix Pharmaceuticals Launches AU$600 Million Convertible Bond Offering to Fund Theranostic Portfolio, Pursue Potential M&As
Telix Pharmaceuticals Ltd. (TLPPF) Receives a Buy From TD Cowen
Telix Pharmaceuticals Target Price Raised 11% to A$22.11/Share by Wilsons>TLX.AU
Bell Potter Sticks to Its Buy Rating for Telix Pharmaceuticals Ltd. (TLPPF)
Telix Pharmaceuticals Price Target Raised 7.1% to A$33.10/Share by Jefferies
Buy This High-flying ASX Healthcare Stock for Market-beating Returns
Analysis
Price Target
No Data
